Clinical Trials
Closed
Phase
Accrual
88%
Published
SWOG Clinical Trial Number
S0127
A Phase II Study of OSI-774 (NSC #718781) in Unresectable or Metastatic Adenocarcinoma of the Stomach and Gastroesophageal Junction
Research Committee(s)
Gastrointestinal Cancer
Activated
06-01-2002
Closed
08-15-2003
Closed
Phase
Accrual
72%
Published
SWOG Clinical Trial Number
S0000A
PREADVISE, Prevention of Alzheimer's Disease with Vitamin E and Selenium, Phase III Ancillary to S0000 - SELECT
Activated
05-17-2002
Closed
09-30-2009
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0218
A Phase II Study of Oral EGFR Tyrosine Kinase Inhibitor OSI-774 (NSC-718781) In Patients with Malignant Pleural Mesothelioma
Research Committee(s)
Sarcoma
Lung Cancer
Activated
05-01-2002
Closed
04-01-2003
Closed
Phase
Accrual
77%
Published
SWOG Clinical Trial Number
S0211
A Phase II Trial of STI571 for the Treatment of Platinum and Taxane Refractory Stage III and IV Epithelial Ovarian Cancer and Primary Peritoneal Cancer
Research Committee(s)
Gynecologic Cancer
Activated
04-15-2002
Closed
01-01-2006
Closed
Phase
Accrual
50%
Published
SWOG Clinical Trial Number
S0207
Phase II Study of Arsenic Trioxide in Male Patients with Refractory Germ Cell Malignancies
Research Committee(s)
Genitourinary Cancer
Activated
04-01-2002
Closed
03-01-2005
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0119
Phase II Trial of Gemcitabine and Irinotecan in Patients with Untreated Extensive Stage Small Cell Lung Cancer (SCLC)
Research Committee(s)
Lung Cancer
Activated
01-01-2002
Closed
02-15-2003
Closed
Phase
Accrual
48%
Published
SWOG Clinical Trial Number
S0032
Phase II Evaluation of Early Oral Estramustine, Oral Etoposide and Intravenous Paclitaxel in Combination with Hormone Therapy in Patients with High-Risk Metastatic Adenocarcinoma of the Prostate
Research Committee(s)
Genitourinary Cancer
Activated
12-01-2001
Closed
06-01-2005
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0126
Phase II Trial of Chronic Oral ZD1839 (Iressa) in Both Previously-Untreated and Previously-Treated Patients with Selected Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC)
Research Committee(s)
Lung Cancer
Activated
12-01-2001
Closed
07-01-2003
Closed
Phase
Accrual
62%
Published
SWOG Clinical Trial Number
S0026
Evaluation of Interferon Alpha-2b and Thalidomide in Patients with Disseminated Malignant Melanoma, Phase II
Research Committee(s)
Melanoma
Activated
11-01-2001
Closed
05-01-2003
Closed
Phase
Accrual
46%
Published
SWOG Clinical Trial Number
S0001
A Phase III Study of Radiation Therapy (RT) and O6-Benzylguanine (O6-BG) Plus BCNU versus RT and BCNU Alone for Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma
Research Committee(s)
Brain Cancer
Activated
09-01-2001
Closed
11-15-2005
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0027
Phase II Trial of Sequential Vinorelbine and Docetaxel in Advanced Non-Small Cell Lung Cancer Patients Age Seventy and Older, or with Performance Status 2
Research Committee(s)
Lung Cancer
Activated
09-01-2001
Closed
07-01-2003
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0112
S0112, A Phase II Study Of Daunomycin And Ara-C, Both Given By Continuous IV Infusion For Previously Untreated Non-M3 Acute Myeloid Leukemia (AML) In Patients Of Age 56 Or Older.
Research Committee(s)
Leukemia
Activated
08-01-2001
Closed
04-01-2003
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0000
Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Research Committee(s)
Prevention, Screening, and Surveillance
Genitourinary Cancer
Activated
07-25-2001
Closed
06-24-2004
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0107
A Phase II Trial of Epothilone B Analogue BMS-247550 (NSC #710428) Every 21 Days in Patients With Advanced Pancreas Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
07-01-2001
Closed
06-01-2003
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0111
A Phase II Trial of Epothilone B Analogue BMS-247550 (NSC #710428) (IND 59699) Administered Every 21 Days in Patients with Hormone Refractory Prostate Cancer
Research Committee(s)
Genitourinary Cancer
Activated
06-15-2001
Closed
11-15-2003
Closed
Phase
Accrual
74%
Published
SWOG Clinical Trial Number
S0023
A Phase III Trial of Cisplatin/Etoposide/Radiotherapy with Consolidation Docetacel followed by Maintenance Therapy with ZD1839 (NSC-715055) or Placebo in Patients with Inoperable Locally Advanced Stage III Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
06-15-2001
Closed
04-15-2005
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0012
A Comparative Randomized Study of Standard Doxorubicin And Cyclophosphamide Followed by Weekly Paclitaxel Vs. Weekly Doxorubicin And Daily Oral Cyclophosphamide Plus G-CSF Followed by Weekly Paclitaxel As Neoadjuvant Therapy For Inflammatory And Locally Advanced Breast Cancer
Research Committee(s)
Breast Cancer
Activated
05-01-2001
Closed
12-01-2005
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0102
Docetaxel and Vinorelbine Plus Filgrastim for HER-2 Negative, Stage IV Breast Cancer, Phase II
Research Committee(s)
Breast Cancer
Activated
05-01-2001
Closed
01-01-2004
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0109
A Phase II Study of Flavopiridol (NSC-649890) 1 Hour Bolus Days 1-3 Q 21 Days in Patients with Advanced Renal Cell Cancer
Research Committee(s)
Genitourinary Cancer
Activated
05-01-2001
Closed
02-01-2002
Closed
Phase
Accrual
87%
Published
SWOG Clinical Trial Number
S0108
Bevacizumab (rhuMAb) (NSC 704865) Therapy For Patients With Relapsed Aggressive Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
04-15-2001
Closed
12-01-2004